ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Federico Lussana, Alessandro Rambaldi
  • Federico Lussana
    Hematology and Bone Marrow Transplant Unit A.O. Ospedale Papa Giovanni XXIII Bergamo Piazza OMS, 1 24127 Bergamo ITALY, Italy | flussana@hpg23.it
  • Alessandro Rambaldi
    Hematology and Bone Marrow Transplant Unit A.O. Ospedale Papa Giovanni XXIII Bergamo Piazza OMS, 1 24127 Bergamo ITALY, Italy

Abstract

Adult acute lymphoblastic leukemia (ALL) is a heterogeneous disease, due to the expression of different biological and clinical risk factors, for which allogeneic stem cell transplantation (alloHSCT) is an effective consolidation therapy. The non-relapse mortality of alloHSCT remains significantly higher compared with that of conventional chemotherapy; therefore, one of the main challenges in the care of ALL is to establish a more precise prognostic definition to select patients who could take advantage from an alloHSCT. Currently, the use of minimal residual disease following induction and early consolidation therapy has improved the prognostic accuracy in defining ALL risk class. In Philadelphia-positive ALL, the introduction of tyrosine kinase inhibitors pre and post alloHSCT appears to improve outcomes significantly and, in the absence of specifically designed clinical trials, alloHSCT remains the most effective post- remission therapy. Nowadays, alloHSCT can be performed according to different modalities encompassing the use of different conditioning regimens, as well as different donors and stem cell source, with a significant accessibility to transplant.

Keywords

Acute Lymphoblastic Leukemia; Allogeneic Bone Marrow Transplantation

Full Text:

PDF
HTML
Submitted: 2014-08-29 14:21:53
Published: 2014-10-20 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
836

Views:
PDF
413
HTML
1924

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185